array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(550)
}
["articles"]=>
array(7) {
[0]=>
array(7) {
["title_en"]=>
string(41) "Finance manager Veteran to Elekta's board"
["snippet_en"]=>
string(351) "The radiation therapy company Elekta's election committee proposes the new election of Tomas Eliasson and Volker Wetekam to the board. Getinge's board chairman Johan Malmquist has declined re-election to the Elekta board. This is clear from the nomination committee's proposal for the annual general meeting in Elekta, which will be held on August 24."
["url"]=>
string(64) "https://www.di.se/live/finanschefsveteran-till-elektas-styrelse/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/01d9b7d9-1998-41b7-93f2-7b2a5788545b"
["source"]=>
string(5) "di.se"
["publication_date"]=>
string(10) "2023-06-30"
["categories"]=>
array(1) {
[0]=>
string(12) "Board Change"
}
}
[1]=>
array(7) {
["title_en"]=>
string(17) "Lecta - 03 - Link"
["snippet_en"]=>
string(311) "From left to right Wil-jan Schut (director VDL ETG Eindhoven), Bo-Inge Stensson (Vice President – Procurement Elekta), Marileen Hesse (Senior Strategic Buyer Elekta), Jeroen Boekema (director VDL Konings), Rob Honneff (Business Manager VDL ETG Eindhoven), Dennis van Opzeeland (director VDL ETG Suzhou),"
["url"]=>
string(122) "https://linkmagazine.nl/elekta-verkiest-vdl-groep-tot-leverancier-van-het-jaar-tijdens-mondiale-leveranciersdag/elekta-03/"
["image_url"]=>
NULL
["source"]=>
string(15) "linkmagazine.nl"
["publication_date"]=>
string(10) "2018-09-21"
["categories"]=>
array(2) {
[0]=>
string(12) "Board Change"
[1]=>
string(12) "Staff hiring"
}
}
[2]=>
array(7) {
["title_en"]=>
string(61) "Elekta appoints Niklas Savander as its next President and ..."
["snippet_en"]=>
string(249) "Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working"
["url"]=>
string(136) "https://www.elekta.com/pressreleases/4B4706F6762CB71F/elekta-appoints-niklas-savander-as-its-next-president-and-chief-executive-officer/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1701abce-f3ac-43cf-a263-ee82c56979d4"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2014-05-01"
["categories"]=>
array(4) {
[0]=>
string(20) "Corporate Governance"
[1]=>
string(10) "Executives"
[2]=>
string(12) "Board Change"
[3]=>
string(12) "Staff hiring"
}
}
[3]=>
array(7) {
["title_en"]=>
string(67) "Elekta appoints Niklas Savander as its next President and Chief ..."
["snippet_en"]=>
string(188) "25-10-2013 · Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas …"
["url"]=>
string(134) "https://ir.elekta.com/investors/press-releases/2013/elekta-appoints-niklas-savander-as-its-next-president-and-chief-executive-officer/"
["image_url"]=>
NULL
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2013-10-25"
["categories"]=>
array(4) {
[0]=>
string(20) "Corporate Governance"
[1]=>
string(10) "Executives"
[2]=>
string(12) "Board Change"
[3]=>
string(12) "Staff hiring"
}
}
[4]=>
array(7) {
["title_en"]=>
string(48) "New member of the Elector's Nomination Committee"
["snippet_en"]=>
string(240) "Stockholm
2011-01-3
New member of the Elector's Nomination Committee
Anna Ohlsson-Leijon, representing SEB funds, has been appointed to Elekta’s Nominating Committee. She replaces Tove Bångstad who has left her position at SEB. Anna"
["url"]=>
string(109) "https://www.elekta.com/press/cb837a5f-9d51-4c44-a099-dfde1119b039/new-member-of-elekta-s-nomination-committee"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/919988d0-12c1-49a7-b7b2-72e680401d22"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2011-01-30"
["categories"]=>
array(1) {
[0]=>
string(12) "Board Change"
}
}
[5]=>
array(7) {
["title_en"]=>
string(67) "Webcast of Presentation by Elekta's CEO Tomas Puusepp on February 6"
["snippet_en"]=>
string(250) "Stockholm 2008-02-04 Webcast of Presentation by Elekta 's CEO Tomas Puusepp on February6 On February6, Tomas Puusepp, President& CEO of Elekta will present at Merrill Lynch Global Pharmaceuticals, Biotechnology& Medical Devices Conference in New York"
["url"]=>
string(133) "https://www.elekta.com/press/bc7ee25d-357e-456f-a3f9-e66691a50699/webcast-of-presentation-by-elekta-s-ceo-tomas-puusepp-on-february-6"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/552c1236-b228-4bbd-aac7-ec1f6359300e"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2008-02-04"
["categories"]=>
array(2) {
[0]=>
string(12) "Board Change"
[1]=>
string(5) "Event"
}
}
[6]=>
array(7) {
["title_en"]=>
string(84) "Elekta's Board Decides to Repurchase Own Shares and Adjust Net Debt/Equity Objective"
["snippet_en"]=>
string(245) "Stockholm
2008-01-22
The Board of Directors of Elekta AB (publ) has decided to utilize the authorization the Board received from the Annual General Meeting to repurchase shares in the company. In conjunction, the Board of Directors has also"
["url"]=>
string(150) "https://www.elekta.com/press/52289799-f9f9-4ad7-aee5-fd57f8db1052/elekta-s-board-decides-to-repurchase-own-shares-and-adjust-net-debt-equity-objective"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/febdd7ac-04f7-4646-bd49-a40a58497938"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2008-01-22"
["categories"]=>
array(5) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(15) "Supply & Demand"
[2]=>
string(5) "Debts"
[3]=>
string(12) "Board Change"
[4]=>
string(16) "Share Repurchase"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
550 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
The radiation therapy company Elekta's election committee proposes the new election of Tomas Eliasson and Volker Wetekam to the board. Getinge's board chairman Johan Malmquist has declined re-election to the Elekta board. This is clear from the nomination committee's proposal for the annual general meeting in Elekta, which will be held on August 24.
Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working
25-10-2013 · Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas …
Stockholm
2011-01-3
New member of the Elector's Nomination Committee
Anna Ohlsson-Leijon, representing SEB funds, has been appointed to Elekta’s Nominating Committee. She replaces Tove Bångstad who has left her position at SEB. Anna
Stockholm 2008-02-04 Webcast of Presentation by Elekta 's CEO Tomas Puusepp on February6 On February6, Tomas Puusepp, President& CEO of Elekta will present at Merrill Lynch Global Pharmaceuticals, Biotechnology& Medical Devices Conference in New York
Stockholm
2008-01-22
The Board of Directors of Elekta AB (publ) has decided to utilize the authorization the Board received from the Annual General Meeting to repurchase shares in the company. In conjunction, the Board of Directors has also
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.